Stealth-Body Technology

Making Breakthrough Discoveries
with Stealth-Body Technology

Find out how R&D

Smart Cell Targeting

Stealth-Body

Applied to ADC development, Stealth-Body prevents FcγR-mediated off-target uptake, narrowing the routes by which an antibody reaches cells and tissues it was never meant for.

This reduces antibody uptake by immune cells unrelated to the target, so the drug is delivered more selectively to where it is needed.

Technology film

How Stealth-Body works

3 min 49 sec · English version

Key to the success of
novel drug development

CrossPoint Therapeutics strives to develop drugs that expand the range of curable disease as well as providing dignity and better life to patients.

News & Media

In press media

Check out the latest news about our company below.

Contact

Partnering and licensing inquiries.

Get in touch